Antimicrobial peptides and derived metapeptides

Details for Australian Patent Application No. 2003201281 (hide)

International Classifications

Event Publications

3 April 2003 Complete Application Filed

12 June 2003 Application Open to Public Inspection

Published as AU-B-2003201281

21 October 2004 Change of Name(s) of Applicant(s), Section 104

Harbor-UCLA Research and Education Institute The name of the applicant has been changed to Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center

8 September 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

15 February 2007 Section 223 Application Received

Los Angeles Biomedical Research Institute at HarborUCLA Medical Center An application to extend the time from 17 Feb 2005 to 29 Aug 2006 in which to pay a continuation fee has been filed . Address for service in Australia - Davies Collison Cave 1 Nicholson Street MELBOURNE VIC 3000

5 April 2007 Section 223 Application Allowed

Los Angeles Biomedical Research Institute at HarborUCLA Medical Center The time in which to pay a continuation fee has been extended to 29 Aug 2006. Address for service in Australia - Davies Collison Cave 1 Nicholson Street MELBOURNE VIC 3000

8 January 2009 Application Accepted

Published as AU-B-2003201281

7 May 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.